Informatie:
Fout:
ID
21490
Beschrijving
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00517218
Link
https://clinicaltrials.gov/show/NCT00517218
Trefwoorden
Versies (1)
- 24-04-17 24-04-17 -
Geüploaded op
24 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lymphocytic Leukemia NCT00517218
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
Similar models
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Study Subject untreated | Chronic Lymphocytic Leukemia Intermediate Rai Staging System | Chronic Lymphocytic Leukemia High risk Rai Staging System
Item
previously untreated subjects with intermediate-or high-risk cll(modified rai stages i-iv)
boolean
C0681850 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C1514715 (UMLS CUI [2,3])
C0023434 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
C1514715 (UMLS CUI [3,3])
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C1514715 (UMLS CUI [2,3])
C0023434 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
C1514715 (UMLS CUI [3,3])
Measurable Disease | Chronic Lymphocytic Leukemia
Item
measurable disease as primarily established by the national cancer institute-sponsored working group(nci-wg) guidelines for the diagnosis of cll
boolean
C1513041 (UMLS CUI [1])
C0023434 (UMLS CUI [2])
C0023434 (UMLS CUI [2])
Disease Requirement Therapeutic procedure
Item
requiring therapy for active disease, as primarily defined by the nci-wg guidelines
boolean
C0012634 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group performance status < 2
boolean
C1520224 (UMLS CUI [1])
Organ function
Item
adequate organ function determined , 14 days prior to the first dose of study medication
boolean
C0678852 (UMLS CUI [1])
Absolute lymphocyte count
Item
absolute lymphocyte count > 100,000/ul
boolean
C3544087 (UMLS CUI [1])
Chemotherapy Chronic Lymphocytic Leukemia | Therapeutic procedure Chronic Lymphocytic Leukemia | Transplantation, Homologous
Item
prior chemotherapy or other therapy for cll, including allogeneic transplant
boolean
C0392920 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0040739 (UMLS CUI [3])
C0023434 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0040739 (UMLS CUI [3])
major surgery
Item
less than 3 weeks from any prior major surgery at the time of informed consent
boolean
C0679637 (UMLS CUI [1])
Operative Surgical Procedures Adverse effects Serious | Recovering failed
Item
failure to recover from any serious adverse effect of surgery
boolean
C0543467 (UMLS CUI [1,1])
C0879626 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0521108 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0879626 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0521108 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
Autoimmune hemolytic anemia | Autoimmune thrombocytopenia
Item
history of autoimmune hemolytic anemia or autoimmune thrombocytopenia
boolean
C0002880 (UMLS CUI [1])
C0242584 (UMLS CUI [2])
C0242584 (UMLS CUI [2])
Communicable Disease Serious | Anti-infective therapy Systemic Patient need for
Item
active serious infection requiring systemic anti-infective therapy
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1141958 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
C0205404 (UMLS CUI [1,2])
C1141958 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])